Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

SELL
$4.56 - $6.59 $128,295 - $185,409
-28,135 Reduced 26.71%
77,200 $433,000
Q3 2023

Nov 09, 2023

SELL
$5.2 - $7.32 $31,226 - $43,956
-6,005 Reduced 5.39%
105,335 $654,000
Q2 2023

Aug 14, 2023

BUY
$4.11 - $6.81 $15,145 - $25,094
3,685 Added 3.42%
111,340 $710,000
Q4 2022

Feb 02, 2023

SELL
$3.75 - $7.69 $210 - $430
-56 Reduced 0.05%
107,655 $486,000
Q3 2022

Nov 14, 2022

SELL
$7.21 - $9.47 $53,094 - $69,737
-7,364 Reduced 6.4%
107,711 $808,000
Q1 2022

May 09, 2022

BUY
$7.26 - $8.53 $62,813 - $73,801
8,652 Added 8.13%
115,075 $936,000
Q4 2021

Feb 10, 2022

BUY
$7.76 - $10.23 $131,268 - $173,050
16,916 Added 18.9%
106,423 $890,000
Q3 2021

Nov 09, 2021

SELL
$9.11 - $10.96 $14,730 - $17,722
-1,617 Reduced 1.77%
89,507 $914,000
Q2 2021

Aug 12, 2021

BUY
$8.45 - $11.72 $7,537 - $10,454
892 Added 0.99%
91,124 $936,000
Q4 2020

Feb 12, 2021

SELL
$8.39 - $13.27 $452,690 - $715,996
-53,956 Reduced 37.42%
90,232 $974,000
Q3 2020

Nov 12, 2020

SELL
$7.05 - $10.2 $182,418 - $263,925
-25,875 Reduced 15.21%
144,188 $1.33 Million
Q1 2020

May 04, 2020

SELL
$4.19 - $8.62 $16,797 - $34,557
-4,009 Reduced 2.3%
170,063 $1.26 Million
Q4 2019

Feb 10, 2020

BUY
$5.12 - $8.33 $183,500 - $298,547
35,840 Added 25.93%
174,072 $1.45 Million
Q2 2019

Aug 15, 2019

BUY
$7.51 - $10.12 $437,532 - $589,591
58,260 Added 72.85%
138,232 $1.08 Million
Q1 2019

May 15, 2019

BUY
$7.89 - $12.23 $55,600 - $86,184
7,047 Added 9.66%
79,972 $783,000
Q4 2018

Feb 06, 2019

SELL
$7.29 - $15.27 $40,197 - $84,198
-5,514 Reduced 7.03%
72,925 $570,000
Q3 2018

Oct 16, 2018

SELL
$5.82 - $17.47 $136,903 - $410,946
-23,523 Reduced 23.07%
78,439 $1.37 Million
Q2 2018

Jul 17, 2018

BUY
$3.6 - $7.27 $367,063 - $741,263
101,962 New
101,962 $646,000

Others Institutions Holding CSBR

About CHAMPIONS ONCOLOGY, INC.


  • Ticker CSBR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,522,400
  • Market Cap $102M
  • Description
  • Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...
More about CSBR
Track This Portfolio

Track Essex Investment Management CO LLC Portfolio

Follow Essex Investment Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.